{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:22:36Z","timestamp":1790403756147,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40620-016-0295-4","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T17:18:54Z","timestamp":1459271934000},"page":"881-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial\/pulmonary cells: when the dosage does matter in transplantation"],"prefix":"10.1093","volume":"29","author":[{"given":"Paola","family":"Tomei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Masola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Bellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Carrat\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ficial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Anna","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Onisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onofrio","family":"Resta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Chilosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"key":"295_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF et al (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol Cell 22:159\u2013168","journal-title":"Mol Cell"},{"issue":"11","key":"295_CR2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nrd3531","volume":"10","author":"D Benjamin","year":"2011","unstructured":"Benjamin D, Colombi M, Moroni C, Hall MN (2011) Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov 10(11):868\u2013880","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"295_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1517\/14740338.2013.752814","volume":"12","author":"N Pallet","year":"2013","unstructured":"Pallet N, Legendre C (2013) Adverse events associated with mTOR inhibitors. Expert Opin Drug Saf 12(2):177\u2013186","journal-title":"Expert Opin Drug Saf"},{"issue":"8 Suppl","key":"295_CR4","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/TP.0b013e3181a05b7a","volume":"87","author":"G Stallone","year":"2009","unstructured":"Stallone G, Infante B, Grandaliano G, Gesualdo L (2009) Management of side effects of sirolimus therapy. Transplantation 87(8 Suppl):S23\u2013S26","journal-title":"Transplantation"},{"issue":"9","key":"295_CR5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ejca.2011.02.014","volume":"47","author":"C Porta","year":"2011","unstructured":"Porta C, Osanto S, Ravaud A, Climent MA, Vaishampayan U, White DA et al (2011) Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma. Eur J Cancer 47(9):1287\u20131298","journal-title":"Eur J Cancer"},{"key":"295_CR6","doi-asserted-by":"crossref","first-page":"403280","DOI":"10.1155\/2013\/403280","volume":"2013","author":"G Zaza","year":"2013","unstructured":"Zaza G, Tomei P, Ria P, Granata S, Boschiero L, Lupo A (2013) Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors. Clin Dev Immunol 2013:403280","journal-title":"Clin Dev Immunol"},{"key":"295_CR7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131\u2013142","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"295_CR8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178\u2013196","journal-title":"Nat Rev Mol Cell Biol"},{"key":"295_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-9966-28-28","volume":"28","author":"KO Hong","year":"2009","unstructured":"Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP et al (2009) Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. J Exp Clin Cancer Res 28:28","journal-title":"J Exp Clin Cancer Res"},{"key":"295_CR10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1479-5876-11-292","volume":"11","author":"V Masola","year":"2013","unstructured":"Masola V, Zaza G, Granata S, Gambaro G, Onisto M, Lupo A (2013) Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. J Trans Med 11:292","journal-title":"J Trans Med"},{"issue":"4","key":"295_CR11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1535-7163.MCT-08-0668","volume":"8","author":"M Breuleux","year":"2009","unstructured":"Breuleux M, Klopfenstein M, Stephan C, Doughty CA, Barys L, Maira SM et al (2009) Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3\u00a0K\/mTOR inhibition. Mol Cancer Ther 8(4):742\u2013753","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"295_CR12","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","volume":"26","author":"X Wan","year":"2007","unstructured":"Wan X, Harkavy B, Shen N, Grohar P, Helman LJ (2007) Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26(13):1932\u20131940","journal-title":"Oncogene"},{"issue":"4","key":"295_CR13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","volume":"12","author":"PT Bhaskar","year":"2007","unstructured":"Bhaskar PT, Hay N (2007) The two TORCs and Akt. Dev Cell 12(4):487\u2013502","journal-title":"Dev Cell"},{"key":"295_CR14","first-page":"3065","volume":"118","author":"A Carracedo","year":"2008","unstructured":"Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A et al (2008) Inhibition of mTORC1 leads to MAPK pathway activation through a PI3\u00a0K-dependent feedback loop in human cancer. J Clin Invest 118:3065\u20133074","journal-title":"J Clin Invest"},{"issue":"4","key":"295_CR15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40620-015-0216-y","volume":"28","author":"G Zaza","year":"2015","unstructured":"Zaza G, Masola V, Granata S, Bellin G, Dalla Gassa A, Onisto M, Gambaro G, Lupo A (2015) Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. J Nephrol 28(4):431\u2013440","journal-title":"J Nephrol"},{"issue":"15","key":"295_CR16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12876-015-0347-6","volume":"14","author":"V Masola","year":"2015","unstructured":"Masola V, Carraro A, Zaza G, Bellin G, Montin U, Violi P, Lupo A, Tedeschi U (2015) Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. BMC Gastroenterol 14(15):118","journal-title":"BMC Gastroenterol"},{"key":"295_CR17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/thx.2004.040022","volume":"62","author":"MB Gotway","year":"2007","unstructured":"Gotway MB, Freemer MM, King TE Jr (2007) Challenges in pulmonary fibrosis. 1: use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias. Thorax 62:546\u2013553","journal-title":"Thorax"},{"key":"295_CR18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft T, Simpson JM, Timbrell V (1988) Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41:467\u2013470","journal-title":"J Clin Pathol"},{"issue":"3","key":"295_CR19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","volume":"26","author":"J Wanger","year":"2005","unstructured":"Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F et al (2005) ATS\/ERS task force. Standardisation of lung function testing. Standardisation of the measurement of lung volumes. Eur Respir J 26(3):511\u2013522","journal-title":"Eur Respir J"},{"issue":"5","key":"295_CR20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00007890-200109150-00008","volume":"72","author":"E Morelon","year":"2001","unstructured":"Morelon E, Stern M, Isra\u00ebl-Biet D, Correas JM, Danel C, Mamzer-Bruneel MF et al (2001) Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation 72(5):787\u2013790","journal-title":"Transplantation"},{"issue":"8","key":"295_CR21","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/j.transproceed.2010.07.066","volume":"42","author":"P Errasti","year":"2010","unstructured":"Errasti P, Izquierdo D, Mart\u00edn P, Errasti M, Slon F, Romero A et al (2010) Pneumonitis associated with mammalian target of rapamycin inhibitors in renal transplant recipients: a single-center experience. Transpl Proc 42(8):3053\u20133054","journal-title":"Transpl Proc"},{"issue":"6","key":"295_CR22","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.transproceed.2009.06.003","volume":"41","author":"A Rodr\u00edguez-Moreno","year":"2009","unstructured":"Rodr\u00edguez-Moreno A, Ridao N, Garc\u00eda-Ledesma P, Calvo N, P\u00e9rez-Flores I, Marques M et al (2009) Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center. Transpl Proc 41(6):2163\u20132165","journal-title":"Transpl Proc"},{"issue":"10","key":"295_CR23","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/ndt\/gfn401","volume":"23","author":"S Alexandru","year":"2008","unstructured":"Alexandru S, Ortiz A, Baldovi S, Milicua JM, Ru\u00edz-Escribano E, Egido J et al (2008) Severe everolimus associated pneumonitis in a renal transplant recipient. Nephrol Dial Transpl 23(10):3353\u20133355","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"295_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-144-7-200604040-00009","volume":"144","author":"L Champion","year":"2006","unstructured":"Champion L, Stern M, Isra\u00ebl-Biet D, Mamzer-Bruneel MF, Peraldi MN, Kreis H et al (2006) Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Annals Ann Intern Med 144(7):505\u2013509","journal-title":"Annals Ann Intern Med"},{"issue":"8","key":"295_CR25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.TP.0000118413.92211.B6","volume":"77","author":"PT Pham","year":"2004","unstructured":"Pham PT, Pham PC, Danovitch GM, Ross DJ, Gritsch HA, Kendrick EA et al (2004) Sirolimus associated pulmonary toxicity. Transplantation 77(8):1215\u20131220","journal-title":"Transplantation"},{"issue":"11","key":"295_CR26","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201108-1420PP","volume":"185","author":"TJ Doyle","year":"2012","unstructured":"Doyle TJ, Hunninghake GM, Rosas IO (2012) Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med 185(11):1147\u20131153","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"295_CR27","first-page":"517","volume":"18","author":"H Kage","year":"2012","unstructured":"Kage H, Borok Z (2012) EMT and interstitial lung disease: a mysterious relationship. Curr Opin Pulm Med 18(5):517\u2013523","journal-title":"Curr Opin Pulm Med"},{"issue":"10","key":"295_CR28","first-page":"2658","volume":"63","author":"C Gilles","year":"2003","unstructured":"Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, Foidart JM (2003) Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 63(10):2658\u20132664","journal-title":"Cancer Res"},{"issue":"22","key":"295_CR29","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1158\/0008-5472.CAN-13-0560","volume":"73","author":"I Mikaelian","year":"2013","unstructured":"Mikaelian I, Malek M, Gadet R, Viallet J, Garcia A, Girard-Gagnepain A, Hesling C, Gillet G, Gonzalo P, Rimokh R, Billaud M (2013) Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-\u03b2-independent mechanism. Cancer Res 73(22):6621\u20136631","journal-title":"Cancer Res"},{"issue":"56","key":"295_CR30","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1204091","volume":"19","author":"M Hidalgo","year":"2000","unstructured":"Hidalgo M, Rowinsky EK (2000) The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19(56):6680\u20136686","journal-title":"Oncogene"},{"issue":"2","key":"295_CR31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jtcvs.2010.10.006","volume":"141","author":"VM Felton","year":"2011","unstructured":"Felton VM, Inge LJ, Willis BC, Bremner RM, Smith MA (2011) Immunosuppression-induced bronchial epithelial-mesenchymal transition: a potential contributor to obliterative bronchiolitis. J Thorac Cardiovasc Surg 141(2):523\u2013530","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"295_CR32","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1177\/1535370213498976","volume":"238","author":"X Xu","year":"2013","unstructured":"Xu X, Wan X, Geng J, Li F, Yang T, Dai H (2013) Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase. Exp Biol Med (Maywood) 238(9):1082\u20131094","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"295_CR33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40620-014-0103-y","volume":"27","author":"G Zaza","year":"2014","unstructured":"Zaza G, Granata S, Tomei P, Masola V, Gambaro G, Lupo A (2014) mTOR inhibitors and renal allograft: Yin and Yang. J Nephrol 27(5):495\u2013506","journal-title":"J Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0295-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-016-0295-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0295-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0295-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:10Z","timestamp":1777564630000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/29\/6\/881\/8371315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["295"],"URL":"https:\/\/doi.org\/10.1007\/s40620-016-0295-4","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}